![Ace Report Cover](https://myoe.blob.core.windows.net/images/cd3177e5a7a18217e3a2db11e74a80ed.png)
Efficacy of Radiofrequency Microdebridement (TOPAZ) in Tendinopathy: A Meta-Analysis
![Ace Report Cover](https://myoe.blob.core.windows.net/images/cd3177e5a7a18217e3a2db11e74a80ed.png)
Efficacy of Radiofrequency Microdebridement (TOPAZ) in Tendinopathy: A Meta-Analysis
Efficacy of radiofrequency microdebridement (TOPAZ) in tendinopathy: a systematic review and meta-analysis of randomised clinical trials
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Nine randomized controlled trials including patients with lateral elbow, shoulder, Achilles, and greater trochanteric pain syndrome (GTPS) tendinopathies were included in this systematic review and meta-analysis comparing radiofrequency microdebridement (RM) vs. other treatment modalities. Pooled outcomes of interest included short-term pain and function, mid-term pain and function, long-term pain...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
![Ace Report Preview Image](https://myoe.blob.core.windows.net/images/AceReport-Blur-LG.jpg)
Learn about our AI Driven
High Impact Search Feature
![High Impact Icon](/Images/High_Impact_Icon.png)
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.